NIH

Adobe Stock

The National Institutes of Health has begun a clinical trial on a drug designed to treat cravings associated with opioid use disorder. 

There are a handful of drugs already on the market that are commonly used to treat OUD such as methadone, buprenorphine and naltrexone. But these are either synthetic opioids or have little impact on cravings specifically. The new drug, if successful, will focus on targeting the cravings felt by some patients who have OUD – and hopefully help them maintain sobriety.

United for Medical Research

In its proposed budget released this week, the Trump administration called for big cuts to national medical and science funding institutions. In response, a medical research advocacy organization has published a brief on the impact of National Institutes of Health funding.